Join the 200th Anniversary Celebration

Original Article

The Interval between Pregnancies and the Risk of Preeclampsia

Rolv Skjærven, Ph.D., Allen J. Wilcox, M.D., Ph.D., and Rolv T. Lie, Ph.D.

N Engl J Med 2002; 346:33-38January 3, 2002

Abstract

Background

The risk of preeclampsia is generally lower in second pregnancies than in first pregnancies, but not if the mother has a new partner for the second pregnancy. One explanation is that the risk is reduced with repeated maternal exposure and adaptation to specific antigens from the same partner. However, the difference in risk might instead be explained by the interval between births. A longer interbirth interval may be associated with both a change of partner and a higher risk of preeclampsia.

Methods

We used data from the Medical Birth Registry of Norway, a population-based registry that includes births that occurred between 1967 and 1998. We studied 551,478 women who had two or more singleton deliveries and 209,423 women who had three or more singleton deliveries.

Results

Preeclampsia occurred during 3.9 percent of first pregnancies, 1.7 percent of second pregnancies, and 1.8 percent of third pregnancies when the woman had the same partner. The risk in a second or third pregnancy was directly related to the time that had elapsed since the preceding delivery, and when the interbirth interval was 10 years or more, the risk approximated that among nulliparous women. After adjustment for the presence or absence of a change of partner, maternal age, and year of delivery, the odds ratio for preeclampsia for each one-year increase in the interbirth interval was 1.12 (95 percent confidence interval, 1.11 to 1.13). In unadjusted analyses, a pregnancy involving a new partner was associated with higher risk of preeclampsia, but after adjustment for the interbirth interval, the risk of preeclampsia was reduced (odds ratio for preeclampsia with a change of partner, 0.73; 95 percent confidence interval, 0.66 to 0.81).

Conclusions

The protective effect of previous pregnancy against preeclampsia is transient. After adjustment for the interval between births, a change of partner is not associated with an increased risk of preeclampsia.

Media in This Article

Figure 1Risk of Preeclampsia during Second and Third Pregnancies, According to the Interval since the Previous Delivery, for Women with No History of Preeclampsia and the Same Partner for All Pregnancies.
Figure 2Risk of Preeclampsia during the Second Pregnancy, According to the Interval since the First Delivery, with the Same or a Different Partner, for Women with No History of Preeclampsia.
Article

Preeclampsia is a transient but potentially dangerous complication of pregnancy that affects 3 to 5 percent of pregnant women.1,2 Although the causes of preeclampsia remain uncertain,3 epidemiologic features of the condition have led to speculation about immunologic causes. The risk of preeclampsia is at least twice as high during first pregnancies as during second or later pregnancies.4-6 Recent studies have suggested that the risk may decrease with a second pregnancy only if the mother's partner is the same.1,7 The hypothesis is that the risk of preeclampsia may be reduced with repeated maternal exposure and adaptation to specific foreign antigens of the partner.3,8,9 According to this hypothesis, a new partner presents new antigens, which results in a risk of preeclampsia that is similar to the risk during a first pregnancy. However, it is also possible that the increased risk of preeclampsia associated with a change of partner might be attributable to a longer interval since the previous delivery, which may also increase the risk of preeclampsia.5,10 We used a large registry in Norway to evaluate the effects on the risk of preeclampsia of both the interbirth interval and a change of partner.

Methods

Data on Deliveries

We used data from the Medical Birth Registry of Norway, comprising the records of more than 1.8 million births between 1967 and 1998. Stillbirths occurring after 16 weeks or more of gestation are also reported to the registry. The registry contains a unique personal identification number for all mothers, all liveborn children, and nearly all fathers.

All children born to a given woman were linked by means of the national identification number of the woman. We identified 551,478 sets (7.6 percent) of first and second singleton deliveries that occurred during this period. Of these, 509,548 of the pairs (92.4 percent) had the same father, and 31,683 pairs (5.7 percent) had different fathers; for the remaining 10,247 pairs (1.9 percent), it could not be determined whether the father was the same. Similarly, we identified 209,423 sets of first, second, and third singleton deliveries. Of these, 158,284 sets (7.6 percent) had the same father; in the case of 24,252 sets (11.6 percent), the partner had changed either between the first and second deliveries (4.6 percent) or between the second and third deliveries (7.0 percent). For the remaining 26,887 sets (12.8 percent), information on the father was missing for at least one pregnancy.

Calculation of Interbirth Interval

The interbirth interval was calculated as the time (in days) between two consecutive birth dates. We used birth dates (rather than approximate dates of conception) for calculating the interbirth interval because this information was virtually 100 percent complete, whereas information on the gestational age (which is necessary for estimating the date of conception) was more often missing or unreliable. The effect of using the birth date rather than the estimated date of conception was expected to be minimal for the present analysis, which focuses on longer interbirth intervals. The interbirth interval was categorized according to completed years (e.g., an interbirth interval of two years indicates a period of at least two years and less than three years).

Definition of Preeclampsia

Preeclampsia was defined as an increase in blood pressure to at least 140/90 mm Hg after the 20th week of gestation, an increase in diastolic blood pressure of at least 15 mm Hg from the level measured before the 20th week, or an increase in systolic blood pressure of at least 30 mm Hg from the level measured before the 20th week, combined with proteinuria (protein excretion, at least 0.3 g per 24 hours).11 A diagnosis of preeclampsia in the medical record is routinely entered on the medical registration form as a specified diagnosis by the midwife or obstetrician. In some cases, the registration form contains information on the presence of hypertension, proteinuria, or edema during pregnancy. We included as cases of preeclampsia all pregnancies with a specified diagnosis of preeclampsia and pregnancies with a combination of pregnancy-related hypertension and proteinuria.5

Statistical Analysis

We used stratification and logistic-regression techniques to evaluate possible confounding. In these analyses, we divided the deliveries into three periods according to the year (1967 to 1976, 1977 to 1986, and 1987 to 1998) and maternal age into five categories (less than 20 years, 20 to 24 years, 25 to 29 years, 30 to 34 years, and 35 years or more). In assessing the interbirth interval, we used the mother's age at the time of the later delivery and the period during which that delivery occurred. Age and period were treated as categorical variables, and the interval between pregnancies was treated as a linear variable, categorized into 10 groups according to completed years (with <1 year included in the 1-year category and >10 years included in the 10-year category). For the interbirth interval, the main variable of interest, we report the increase in risk with each additional year between deliveries as an estimated odds ratio. For most analyses, the data were restricted to women with no history of preeclampsia during previous pregnancies and to the pregnancies of women who had the same partner for all pregnancies. We only considered pregnancies that led to a recorded birth, including stillbirths that occurred after at least 16 weeks of gestation.

Results

Risk of Preeclampsia According to Parity

Preeclampsia occurred during 3.9 percent of first pregnancies. When subsequent pregnancies involved the same partner, preeclampsia occurred during 1.7 percent of second pregnancies and 1.8 percent of third pregnancies (Table 1Table 1Risk of Preeclampsia during First, Second, and Third Singleton Pregnancies.). When women with previous preeclampsia were excluded, preeclampsia occurred during only 1.3 percent of second and third pregnancies (Table 1).

The Effect of the Interval between Deliveries

Among women with no history of preeclampsia, the median interbirth interval was 2.9 years between the first and the second deliveries and 3.6 years between the second and the third deliveries. The risk of preeclampsia during the second pregnancy was found to increase steadily as the time since the first delivery increased (Figure 1Figure 1Risk of Preeclampsia during Second and Third Pregnancies, According to the Interval since the Previous Delivery, for Women with No History of Preeclampsia and the Same Partner for All Pregnancies.). The estimated odds ratio for preeclampsia was 1.16 per additional year (95 percent confidence interval, 1.15 to 1.18). By 10 years after the first pregnancy, the risk of preeclampsia had more than tripled, nearly reaching the level of the risk found among nulliparous women. An increasing interval between the second and the third deliveries was similarly associated with an increasing risk of preeclampsia (Figure 1).

The risk of preeclampsia is known to increase with maternal age,12 and this relation might contribute to an apparent increase in risk with an increasing interbirth interval. Nonetheless, the increased risk of preeclampsia associated with an increasing interbirth interval remained after we controlled for maternal age (in five-year categories) (odds ratio, 1.13 per year; 95 percent confidence interval, 1.12 to 1.14). An analysis that adjusted for maternal age with the use of one-year age categories gave the same results.

There was a moderate increase in the risk of preeclampsia during the first 15 years of the birth registry (1967 to 1982), and the risk remained stable thereafter. When we adjusted for the year of delivery, the results were essentially unchanged (data not shown).

Finally, we considered the possibility that the increase in the risk of preeclampsia with an increasing interbirth interval could be confounded by an association between preeclampsia and subfertility. If less fertile women are at higher risk for preeclampsia, then the increase in the risk of preeclampsia with an increasing interbirth interval could be attributable to the overrepresentation of less fertile women. However, we found no association between the risk of preeclampsia in the first pregnancy and the interval between the first and second pregnancies (odds ratio for preeclampsia in the first pregnancy, 1.01 per year; 95 percent confidence interval, 0.99 to 1.01).

Effect of a Change of Partner

The association between an increasing interbirth interval and an increasing risk of preeclampsia might be explained by the fact that a change of partner is more common among the women with longer interbirth intervals. In our cohort, about 6 percent of the women changed their partners between their first and second pregnancies. The median time to the second delivery when the partner remained the same was 2.9 years, as compared with 5.9 years with a change of partner (Table 2Table 2Time since the Previous Pregnancy and the Risk of Preeclampsia among Women with the Same or a Different Partner.). Similarly, the median time from the second to the third delivery was 3.6 years when the partner remained the same and 7.5 years with a change of partner. Among women with no history of preeclampsia, the complication occurred during 1.3 percent of second pregnancies for which the partner remained the same and 1.5 percent of those for which there was a change of partner. This excess risk of preeclampsia for women who changed partners as compared with those who remained with the same partner was small but statistically significant (odds ratio, 1.14; 95 percent confidence interval, 1.04 to 1.26) (Table 3Table 3Change of Partner, Interbirth Interval, and the Risk of Preeclampsia.). The risk of preeclampsia was similarly increased for the third pregnancy if there was a different partner (odds ratio, 1.42; 95 percent confidence interval, 1.25 to 1.62).

We assessed the association between the interbirth interval and the risk of preeclampsia during the second pregnancy, stratifying the women according to whether or not their partner was the same for both pregnancies. A strong effect of the interbirth interval was seen regardless of change or lack of change of partner (Figure 2Figure 2Risk of Preeclampsia during the Second Pregnancy, According to the Interval since the First Delivery, with the Same or a Different Partner, for Women with No History of Preeclampsia.). The effect of changing the partner was eliminated when the interbirth interval was taken into account. In fact, after the interval had been taken into account, the risk of preeclampsia was lower for pregnancies involving a new partner than for those involving the same partner (Figure 2).

We also used multivariate analysis to assess simultaneously the effects of the interbirth interval and change or lack of change of partner on the risk of preeclampsia (Table 3). After adjustment for the interbirth interval, a change of partner was no longer associated with an increased risk of preeclampsia but, rather, with a significantly decreased risk of this complication. The results were essentially the same after further adjustment for maternal age and the period when the delivery occurred (Table 3).

These analyses included stillbirths that had occurred as early as 16 weeks after gestation began. Since preeclampsia typically occurs later in pregnancy, we reanalyzed the data for second deliveries excluding stillbirths that had occurred at less than 21 weeks of gestation. The associations of the interbirth interval and a change of partner with the risk of preeclampsia were materially unchanged.

Discussion

We found that multiparous women who are pregnant 10 years or more after their previous pregnancy are as likely to have preeclampsia as nulliparous women. Preeclampsia has been described as “a disease of first pregnancy”3,13,14 and is sometimes defined as occurring only among nulliparous women. Although our data confirm that the risk of preeclampsia falls sharply after the first pregnancy, we also found that the risk subsequently increases over time. This striking increase in risk with an increasing interbirth interval suggests that the benefit of higher parity in terms of the risk of preeclampsia is only transient.

A change of partner has been thought to increase the risk of preeclampsia.1,7,13,15 This observation is likely to be confounded by the effect of the interbirth interval. The apparent increase in the risk of preeclampsia with a change of partner has been interpreted as support for the hypothesis that a failure of the immune system to adapt to the partner's antigens causes preeclampsia. This theory was proposed in 1975 in a case report of preeclampsia during the second pregnancy of a woman who changed her partner after having her first child.16 This has led to extensive speculation about possible immune mechanisms related to a change of partner.3,8,9,14,16-18 Our data suggest that after appropriate adjustment for the interbirth interval, there is no increased risk associated with a change of partner. The observed association between the interbirth interval and the risk of preeclampsia may be relevant in interpreting the results of other studies of risk factors for preeclampsia. For example, miscarriage has been associated with a reduction in the risk of preeclampsia in a subsequent pregnancy.4,12,19 This result might be explained by the fact that the average interval between pregnancies is shorter after a miscarriage than after a live birth.20 Also, artificial insemination with donor semen and the use of donated oocytes have been reported to increase the risk of preeclampsia.21,22 Women who receive these treatments have often been trying for a long time to become pregnant.

Although the influence of the time since a previous pregnancy appears to be as strong as that of any of the known risk factors for preeclampsia, the recognition of this association should not be taken as a recommendation of short intervals between pregnancies. Other adverse outcomes of pregnancy — most notably preterm delivery — are more likely with very short intervals.23 In terms of these other adverse outcomes, the lower limit of the interval at which high risk is attenuated varies, ranging from 6 months between delivery and subsequent conception in developed countries to 18 months in developing countries.24

Our study has some limitations. We do not have data on the smoking status of the women, which may confound the association between a change of partner and the risk of preeclampsia. Many pregnant women in Norway smoke,25,26 and smoking may be more common among women whose marriages end in divorce.27 If so, smoking may be more frequent among women who later become pregnant by a new partner. Since smoking is associated with a reduction in the risk of preeclampsia,4,12,28 this set of associations might explain the lower risk of preeclampsia observed among women who change partners.

Another limitation is the lack of data on obesity. Obesity is associated with an increased risk of preeclampsia.4,12 The risk of obesity increases with a woman's age and parity. However, if increasing weight were contributing to the effect of the interbirth interval, we would have expected a higher risk of preeclampsia during the third pregnancy than during the second pregnancy. No such increase was seen (Figure 1).

An extended interval between pregnancies appears to be a major risk factor for preeclampsia, with the risk after 10 years similar to that among nulliparous women. Furthermore, after adjustment for the interbirth interval, a change of partner between one pregnancy and the next is not a risk factor for preeclampsia.

Supported by funds from the Norwegian Foundation for Health and Rehabilitation.

We are indebted to Dr. Donna Baird, Dr. Grace Egeland, Dr. Lorentz M. Irgens, Dr. Kari Klungsøyr Melve, Dr. Svein Rasmussen, and Dr. Clarice Weinberg for their constructive comments on previous versions of the manuscript.

Source Information

From the Section for Medical Statistics, Department of Public Health and Primary Health Care, and the Medical Birth Registry of Norway, Locus for Registry-Based Epidemiology, University of Bergen, Bergen, Norway (R.S., R.T.L.); and the Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, N.C. (A.J.W.).

Address reprint requests to Professor Skjærven at the Section for Medical Statistics, University of Bergen, Armauer Hansens Bldg., 5021 Bergen, Norway, or at .

References

References

  1. 1

    Trupin LS, Simon LP, Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology 1996;7:240-244
    CrossRef | Web of Science | Medline

  2. 2

    Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-56
    CrossRef | Web of Science | Medline

  3. 3

    Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359-1375
    CrossRef | Web of Science | Medline

  4. 4

    Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991;266:237-241
    CrossRef | Web of Science | Medline

  5. 5

    Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998;316:1343-1347
    CrossRef | Web of Science | Medline

  6. 6

    Pipkin FB. Risk factors for preeclampsia. N Engl J Med 2001;344:925-926
    Full Text | Web of Science | Medline

  7. 7

    Robillard PY, Hulsey TC, Alexander GR, Keenan A, de Caunes F, Papiernik E. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J Reprod Immunol 1993;24:1-12
    CrossRef | Web of Science | Medline

  8. 8

    Dekker GA, Robillard PY, Hulsey TC. Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. Obstet Gynecol Surv 1998;53:377-382
    CrossRef | Medline

  9. 9

    Dekker G, Sibai BM. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001;357:209-215
    CrossRef | Web of Science | Medline

  10. 10

    Conde-Agudelo A, Belizan JM. Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study. BMJ 2000;321:1255-1259
    CrossRef | Web of Science | Medline

  11. 11

    Lindheimer MD, Roberts JM, Cunningham FG, Chesley L. Introduction, history, controversies, and definitions. In: Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley's hypertensive disorders in pregnancy. 2nd ed. Stamford, Conn.: Appleton & Lange, 1999:3-41.

  12. 12

    Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 1997;177:1003-1010
    CrossRef | Web of Science | Medline

  13. 13

    Robillard PY, Dekker GA, Hulsey TC. Revisiting the epidemiological standard of preeclampsia: primigravidity or primipaternity? Eur J Obstet Gynecol Reprod Biol 1999;84:37-41
    CrossRef | Web of Science | Medline

  14. 14

    Tubbergen P, Lachmeijer AM, Althuisius SM, Vlak ME, van Geijn HP, Dekker GA. Change in paternity: a risk factor for preeclampsia in multiparous women? J Reprod Immunol 1999;45:81-88
    CrossRef | Web of Science | Medline

  15. 15

    Feeney JG, Scott JS. Pre-eclampsia and changed paternity. Eur J Obstet Gynecol Reprod Biol 1980;11:35-38
    CrossRef | Web of Science | Medline

  16. 16

    Need JA. Pre-eclampsia in pregnancies by different fathers: immunological studies. Br Med J 1975;1:548-549
    CrossRef | Web of Science | Medline

  17. 17

    Need JA. Some immunological aspects of preeclampsia. Perspect Nephrol Hypertens 1976;5:169-176
    Medline

  18. 18

    Dekker GA, Sibai BM. The immunology of preeclampsia. Semin Perinatol 1999;23:24-33
    CrossRef | Web of Science | Medline

  19. 19

    Eras JL, Saftlas AF, Triche E, Hsu CD, Risch HA, Bracken MB. Abortion and its effect on risk of preeclampsia and transient hypertension. Epidemiology 2000;11:36-43
    CrossRef | Web of Science | Medline

  20. 20

    Basso O, Olsen J, Christensen K. Risk of preterm delivery, low birthweight and growth retardation following spontaneous abortion: a registry-based study in Denmark. Int J Epidemiol 1998;27:642-646
    CrossRef | Web of Science | Medline

  21. 21

    Need JA, Bell B, Meffin E, Jones WR. Pre-eclampsia in pregnancy from donor inseminations. J Reprod Immunol 1983;5:329-338
    CrossRef | Web of Science | Medline

  22. 22

    Smith GN, Walker M, Tessier JL, Millar KG. Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. Am J Obstet Gynecol 1997;177:455-458
    CrossRef | Web of Science | Medline

  23. 23

    Zhu B-P, Rolfs RT, Nangle BE, Horan JM. Effect of the interval between pregnancies on perinatal outcomes. N Engl J Med 1999;340:589-594
    Full Text | Web of Science | Medline

  24. 24

    Rawlings JS, Rawlings VB, Read JA. Prevalence of low birth weight and preterm delivery in relation to the interval between pregnancies among white and black women. N Engl J Med 1995;332:69-74
    Full Text | Web of Science | Medline

  25. 25

    Haug K, Irgens LM, Baste V, Markestad T, Skjaerven R, Schreuder P. Secular trends in breastfeeding and parental smoking. Acta Paediatr 1998;87:1023-1027
    CrossRef | Web of Science | Medline

  26. 26

    Haug K, Irgens LM, Skjaerven R, Markestad T, Baste V, Schreuder P. Maternal smoking and birthweight: effect modification of period, maternal age and paternal smoking. Acta Obstet Gynecol Scand 2000;79:485-489
    CrossRef | Web of Science | Medline

  27. 27

    Fu H, Goldman N. The association between health-related behaviours and the risk of divorce in the USA. J Biosoc Sci 2000;32:63-88
    CrossRef | Web of Science | Medline

  28. 28

    Duffus GM, MacGillivray I. The incidence of pre-eclamptic toxaemia in smokers and non-smokers. Lancet 1968;1:994-995
    CrossRef | Web of Science | Medline

Citing Articles (89)

Citing Articles

  1. 1

    Kari Klungsøyr, Nils Halvdan Morken, Lorentz Irgens, Stein Emil Vollset, Rolv Skjaerven. (2012) Secular trends in the epidemiology of pre-eclampsia throughout 40 years in Norway: prevalence, risk factors and perinatal survival. Paediatric and Perinatal Epidemiologyno-no
    CrossRef

  2. 2

    Caren G. Solomon, Ellen W. Seely. (2011) Hypertension in Pregnancy. Endocrinology & Metabolism Clinics of North America 40:4, 847-863
    CrossRef

  3. 3

    Uma C. Perni, Anna-Karin Wikström, Sven Cnattingius, Eduardo Villamor. (2011) Interpregnancy Change in Smoking Habits and Risk of Preeclampsia: A Population-Based Study. American Journal of Hypertension
    CrossRef

  4. 4

    F. Colucci, S. Boulenouar, J. Kieckbusch, A. Moffett. (2011) How does variability of immune system genes affect placentation?. Placenta 32:8, 539-545
    CrossRef

  5. 5

    Tabassum Firoz, Tanya Melnik. (2011) Postpartum evaluation and long term implications. Best Practice & Research Clinical Obstetrics & Gynaecology 25:4, 549-561
    CrossRef

  6. 6

    Jennifer A. Hutcheon, Sarka Lisonkova, K.S. Joseph. (2011) Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology 25:4, 391-403
    CrossRef

  7. 7

    Brianna Cloke, Mark Christian. (2011) The role of androgens and the androgen receptor in cycling endometrium. Molecular and Cellular Endocrinology
    CrossRef

  8. 8

    J. Vanderlelie, A.V.A. Perkins. (2011) Selenium and preeclampsia: A global perspective. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 1:3-4, 213-224
    CrossRef

  9. 9

    Lill Trogstad, Per Magnus, Camilla Stoltenberg. (2011) Pre-eclampsia: Risk factors and causal models. Best Practice & Research Clinical Obstetrics & Gynaecology 25:3, 329-342
    CrossRef

  10. 10

    Gus Dekker, Pierre Yves Robillard, Claire Roberts. (2011) The etiology of preeclampsia: the role of the father. Journal of Reproductive Immunology 89:2, 126-132
    CrossRef

  11. 11

    Serena Bertozzi, Ambrogio P. Londero, Stefania Salvador, Tiziana Grassi, Arrigo Fruscalzo, Lorenza Driul, Diego Marchesoni. (2011) Influence of the couple on hypertensive disorders during pregnancy: A retrospective cohort study. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 1:2, 156-163
    CrossRef

  12. 12

    Ana Sofia Cerdeira, S. Ananth Karumanchi. 2011. Biomarkers in Preeclampsia. , 385-426.
    CrossRef

  13. 13

    Joanna L James, Guy S Whitley, Judith E Cartwright. (2010) Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. The Journal of Pathology 221:4, 363-378
    CrossRef

  14. 14

    Christopher W. G. Redman, Ian L. Sargent. (2010) Immunology of Pre-Eclampsia. American Journal of Reproductive Immunology 63:6, 534-543
    CrossRef

  15. 15

    Puneet Sood, Maria C. Rojas, Zvi Talor. (2010) Renal involvement in nail-patella syndrome: report of three cases. International Urology and Nephrology 42:2, 499-502
    CrossRef

  16. 16

    Michelle Silasi, Bruce Cohen, S. Ananth Karumanchi, Sarosh Rana. (2010) Abnormal Placentation, Angiogenic Factors, and the Pathogenesis of Preeclampsia. Obstetrics and Gynecology Clinics of North America 37:2, 239-253
    CrossRef

  17. 17

    Seema Jain, Priyamvada Sharma, Shobha Kulshreshtha, Govind Mohan, Saroj Singh. (2010) The Role of Calcium, Magnesium, and Zinc in Pre-Eclampsia. Biological Trace Element Research 133:2, 162-170
    CrossRef

  18. 18

    Brett C. Young, Richard J. Levine, S. Ananth Karumanchi. (2010) Pathogenesis of Preeclampsia. Annual Review of Pathology: Mechanisms of Disease 5:1, 173-192
    CrossRef

  19. 19

    Ee Min Kho, Lesley M.E. McCowan, Robyn A. North, Claire T. Roberts, Eliza Chan, Michael A. Black, Rennae S. Taylor, Gustaaf A. Dekker. (2009) Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. Journal of Reproductive Immunology 82:1, 66-73
    CrossRef

  20. 20

    Nir Melamed, Avi Ben-Haroush, Rony Chen, Joseph Pardo, Moshe Hod, Yariv Yogev. (2009) Pregnancy Outcome and Mode of Delivery After a Previous Operative Vaginal Delivery. Obstetrics & Gynecology 114:4, 757-763
    CrossRef

  21. 21

    Yang Xia, Rodney E. Kellems. (2009) Is preeclampsia an autoimmune disease?. Clinical Immunology 133:1, 1-12
    CrossRef

  22. 22

    Rebecca A. Swann, Ann Von Holle, Leila Torgersen, Kelly Gendall, Ted Reichborn-Kjennerud, Cynthia M. Bulik. (2009) Attitudes toward weight gain during pregnancy: Results from the Norwegian mother and child cohort study (MoBa). International Journal of Eating Disorders 42:5, 394-401
    CrossRef

  23. 23

    Samantha D. Smith, Caroline E. Dunk, John D. Aplin, Lynda K. Harris, Rebecca L. Jones. (2009) Evidence for Immune Cell Involvement in Decidual Spiral Arteriole Remodeling in Early Human Pregnancy. The American Journal of Pathology 174:5, 1959-1971
    CrossRef

  24. 24

    A. V. Reisaeter, J. Røislien, T. Henriksen, L. M. Irgens, A. Hartmann. (2009) Pregnancy and Birth After Kidney Donation: The Norwegian Experience. American Journal of Transplantation 9:4, 820-824
    CrossRef

  25. 25

    Cynthia M. Bulik, Ann Von Holle, Anna Maria Siega-Riz, Leila Torgersen, Kari Kveim Lie, Robert M. Hamer, Cecilie Knoph Berg, Patrick Sullivan, Ted Reichborn-Kjennerud. (2009) Birth outcomes in women with eating disorders in the Norwegian Mother and Child cohort study (MoBa). International Journal of Eating Disorders 42:1, 9-18
    CrossRef

  26. 26

    C. O. Chigbu, O. A. Okezie, B. U. Odugu. (2009) Women in southern Nigeria with change in paternity do not have increased incidence of pre-eclampsia. Journal of Obstetrics & Gynaecology 29:2, 94-97
    CrossRef

  27. 27

    Stephen F. Thung, Errol R. Norwitz. 2009. Endocrine Diseases of Pregnancy. , 615-658.
    CrossRef

  28. 28

    Chun Lam, S. Ananth Karumanchi. 2009. Pregnancy and the Kidney. , 483-513.
    CrossRef

  29. 29

    Christopher W.G. Redman, Ian L. Sargent, James M. Roberts. 2009. Immunology of Normal Pregnancy and Preeclampsia. , 129-142.
    CrossRef

  30. 30

    Roberta B. Ness, James M. Roberts. 2009. Epidemiology of Pregnancy-Related Hypertension. , 37-50.
    CrossRef

  31. 31

    Vikse, Bjørn Egil, Irgens, Lorentz M., Leivestad, Torbjørn, Skjærven, Rolv, Iversen, Bjarne M., . (2008) Preeclampsia and the Risk of End-Stage Renal Disease. New England Journal of Medicine 359:8, 800-809
    Full Text

  32. 32

    Dorothea Mostello, Dorina Kallogjeri, Rachata Tungsiripat, Terry Leet. (2008) Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. American Journal of Obstetrics and Gynecology 199:1, 55.e1-55.e7
    CrossRef

  33. 33

    R. T. Mikolajczyk, J. Zhang, J. Ford, J. Grewal. (2008) Effects of Interpregnancy Interval on Blood Pressure in Consecutive Pregnancies. American Journal of Epidemiology 168:4, 422-426
    CrossRef

  34. 34

    Roberta B. Ness, David A. Grainger. (2008) Male reproductive proteins and reproductive outcomes. American Journal of Obstetrics and Gynecology 198:6, 620.e1-620.e4
    CrossRef

  35. 35

    L. Trogstad, P. Magnus, R. Skjaerven, C. Stoltenberg. (2008) Previous abortions and risk of pre-eclampsia. International Journal of Epidemiology 37:6, 1333-1340
    CrossRef

  36. 36

    Teresa Rodrigues, Henrique Barros. (2008) Short interpregnancy interval and risk of spontaneous preterm delivery. European Journal of Obstetrics & Gynecology and Reproductive Biology 136:2, 184-188
    CrossRef

  37. 37

    IRA M BERNSTEIN, MARILYN J CIPOLLA. (2008) HAEMODYNAMIC CONTRIBUTIONS TO THE PATHOGENESIS OF PREECLAMPSIA AND ECLAMPSIA. Fetal and Maternal Medicine Review 19:01,
    CrossRef

  38. 38

    Sharon Maynard, Franklin H. Epstein, S. Ananth Karumanchi. (2008) Preeclampsia and Angiogenic Imbalance. Annual Review of Medicine 59:1, 61-78
    CrossRef

  39. 39

    Cecilie Knoph Berg, Cynthia M. Bulik, Ann Von Holle, Leila Torgersen, Robert Hamer, Patrick Sullivan, Ted Reichborn-Kjennerud. (2008) Psychosocial factors associated with broadly defined bulimia nervosa during early pregnancy: findings from the Norwegian mother and child cohort study. Australian and New Zealand Journal of Psychiatry 42:5, 396-404
    CrossRef

  40. 40

    Shigeru Saito, Masatoshi Sakai, Yasushi Sasaki, Akitoshi Nakashima, Arihiro Shiozaki. (2007) Inadequate tolerance induction may induce pre-eclampsia. Journal of Reproductive Immunology 76:1-2, 30-39
    CrossRef

  41. 41

    Elizabeth A. Bonney. (2007) Preeclampsia: a view through the danger model. Journal of Reproductive Immunology 76:1-2, 68-74
    CrossRef

  42. 42

    Gus Dekker, Pierre-Yves Robillard. (2007) Pre-eclampsia: Is the immune maladaptation hypothesis still standing?. Journal of Reproductive Immunology 76:1-2, 8-16
    CrossRef

  43. 43

    Darios Getahun, Cande V. Ananth, Yinka Oyelese, Martin R. Chavez, Russell S. Kirby, John C. Smulian. (2007) Primary Preeclampsia in the Second Pregnancy. Obstetrics & Gynecology 110:6, 1319-1325
    CrossRef

  44. 44

    Pierre-Yves Robillard, Gustaaf Dekker, Gérard Chaouat, Thomas C. Hulsey. (2007) Etiology of preeclampsia: maternal vascular predisposition and couple disease—mutual exclusion or complementarity?. Journal of Reproductive Immunology 76:1-2, 1-7
    CrossRef

  45. 45

    Clive J. Petry, Ken K. Ong, David B. Dunger. (2007) Does the fetal genotype affect maternal physiology during pregnancy?. Trends in Molecular Medicine 13:10, 414-421
    CrossRef

  46. 46

    CYNTHIA M. BULIK, ANN VON HOLLE, ROBERT HAMER, CECILIE KNOPH BERG, LEILA TORGERSEN, PER MAGNUS, CAMILLA STOLTENBERG, ANNA MARIA SIEGA-RIZ, PATRICK SULLIVAN, TED REICHBORN-KJENNERUD. (2007) Patterns of remission, continuation and incidence of broadly defined eating disorders during early pregnancy in the Norwegian Mother and Child Cohort Study (MoBa). Psychological Medicine 37:08, 1109
    CrossRef

  47. 47

    Allen J. Wilcox. (2007) The analysis of recurrence risk as an epidemiological tool. Paediatric and Perinatal Epidemiology 21:s1, 4-7
    CrossRef

  48. 48

    Zhong-Cheng Luo, Na An, Hai-Rong Xu, Amelie Larante, Francois Audibert, William D. Fraser. (2007) The effects and mechanisms of primiparity on the risk of pre-eclampsia: a systematic review. Paediatric and Perinatal Epidemiology 21:s1, 36-45
    CrossRef

  49. 49

    Jun Zhang, Geeta Patel. (2007) Partner change and perinatal outcomes: a systematic review. Paediatric and Perinatal Epidemiology 21:s1, 46-57
    CrossRef

  50. 50

    Cande V. Ananth, Morgan R. Peltier, Martin R. Chavez, Russell S. Kirby, Darios Getahun, Anthony M. Vintzileos. (2007) Recurrence of Ischemic Placental Disease. Obstetrics & Gynecology 110:1, 128-133
    CrossRef

  51. 51

    Jun Zhang. (2007) Partner change, birth interval and risk of pre-eclampsia: a paradoxical triangle. Paediatric and Perinatal Epidemiology 21:s1, 31-35
    CrossRef

  52. 52

    Olga Basso. (2007) Options and limitations in studies of successive pregnancy outcomes: an overview. Paediatric and Perinatal Epidemiology 21:s1, 8-12
    CrossRef

  53. 53

    Lisa Hilder, Shanthi Sairam, Baskaran Thilaganathan. (2007) Influence of parity on fetal mortality in prolonged pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 132:2, 167-170
    CrossRef

  54. 54

    Monica Rittler, Eduardo E. Castilla, Christina Chambers, Jorge S. Lopez-Camelo. (2007) Risk for gastroschisis in primigravidity, length of sexual cohabitation, and change in paternity. Birth Defects Research Part A: Clinical and Molecular Teratology 79:6, 483-487
    CrossRef

  55. 55

    Christina D. Chambers, Brian H. Chen, Kristin Kalla, Laura Jernigan, Kenneth Lyons Jones. (2007) Novel risk factor in gastroschisis: Change of paternity. American Journal of Medical Genetics Part A 143A:7, 653-659
    CrossRef

  56. 56

    Agustin Conde-Agudelo, Anyeli Rosas-Bermúdez, Ana C. Kafury-Goeta. (2007) Effects of birth spacing on maternal health: a systematic review. American Journal of Obstetrics and Gynecology 196:4, 297-308
    CrossRef

  57. 57

    C MORAN, T SANDOVAL, X DUQUE, S GONZALEZ, S MORAN, J BERMUDEZ. (2006) Increased Insulin Levels Independent of Gestational Overweight in Women with Preeclampsia. Archives of Medical Research 37:6, 749-754
    CrossRef

  58. 58

    Bao-Ping Zhu, Violanda Grigorescu, Thu Le, Mei Lin, Glenn Copeland, Maurice Barone, George Turabelidze. (2006) Labor dystocia and its association with interpregnancy interval. American Journal of Obstetrics and Gynecology 195:1, 121-128
    CrossRef

  59. 59

    Shigeru Saito, Yoshiharu Takeda, Masatoshi Sakai, Masao Nakabayahi, Satoshi Hayakawa. (2006) The incidence of pre-eclampsia among couples consisting of Japanese women and Caucasian men. Journal of Reproductive Immunology 70:1-2, 93-98
    CrossRef

  60. 60

    Federico Prefumo, Ramesh Ganapathy, Basky Thilaganathan, Neil J. Sebire. (2006) Influence of parity on first trimester endovascular trophoblast invasion. Fertility and Sterility 85:4, 1032-1036
    CrossRef

  61. 61

    Darios Getahun, Yinka Oyelese, Hamisu M. Salihu, Cande V. Ananth. (2006) Previous Cesarean Delivery and Risks of Placenta Previa and Placental Abruption. Obstetrics & Gynecology 107:4, 771-778
    CrossRef

  62. 62

    Marion E. Deen, Lieke G. C. Ruurda, Jim Wang, Gustaaf A. Dekker. (2006) Risk factors for preeclampsia in multiparous women: Primipaternity versus the birth interval hypothesis. Journal of Maternal-Fetal and Neonatal Medicine 19:2, 79-84
    CrossRef

  63. 63

    Lill I.S. Trogstad, Camilla Stoltenberg, Per Magnus, Rolv Skjaerven, Lorentz M. Irgens. (2005) Recurrence risk in hyperemesis gravidarum. BJOG: An International Journal of Obstetrics and Gynaecology 112:12, 1641-1645
    CrossRef

  64. 64

    Marina Noris, Norberto Perico, Giuseppe Remuzzi. (2005) Mechanisms of Disease: pre-eclampsia. Nature Clinical Practice Nephrology 1:2, 98-114
    CrossRef

  65. 65

    Myles Wolf, Anand Shah, Chun Lam, Abelardo Martinez, Karen V. Smirnakis, Franklin H. Epstein, Robert N. Taylor, Jeffrey L. Ecker, S. Ananth Karumanchi, Ravi Thadhani. (2005) Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. American Journal of Obstetrics and Gynecology 193:1, 16-22
    CrossRef

  66. 66

    Aaron B. Caughey, Naomi E. Stotland, A Eugene Washington, Gabriel J. Escobar. (2005) Maternal Ethnicity, Paternal Ethnicity, and Parental Ethnic Discordance. Obstetrics & Gynecology 106:1, 156-161
    CrossRef

  67. 67

    S. Ananth Karumanchi, Sharon E. Maynard, Isaac E. Stillman, Franklin H. Epstein, Vikas P. Sukhatme. (2005) Preeclampsia: A renal perspective. Kidney International 67:6, 2101-2113
    CrossRef

  68. 68

    L. Domínguez, P. Vigil-De Gracia. (2005) El intervalo intergenésico: un factor de riesgo para complicaciones obstétricas y neonatales. Clínica e Investigación en Ginecología y Obstetricia 32:3, 122-126
    CrossRef

  69. 69

    Aris T. Papageorghiou, Christina K.H. Yu, Ilse E. Erasmus, Howard S. Cuckle, Kypros H. Nicolaides. (2005) Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG: An International Journal of Obstetrics and Gynaecology 112:6, 703-709
    CrossRef

  70. 70

    Yvonne Jonsson, Leif Matthiesen, Göran Berg, Jan Ernerudh, Katri Nieminen, Christina Ekerfelt. (2005) Indications of an altered immune balance in preeclampsia: A decrease in in vitro secretion of IL-5 and IL-10 from blood mononuclear cells and in blood basophil counts compared with normal pregnancy. Journal of Reproductive Immunology 66:1, 69-84
    CrossRef

  71. 71

    SHARON E. MAYNARD, SHIVALINGAPPA VENKATESHA, RAVI THADHANI, S ANANTH KARUMANCHI. (2005) Soluble Fms-like Tyrosine Kinase 1 and Endothelial Dysfunction in the Pathogenesis of Preeclampsia. Pediatric Research 57:5 Part 2, 1R-7R
    CrossRef

  72. 72

    Richard Lafayette. (2005) The kidney in preeclampsia. Kidney International 67:3, 1194-1203
    CrossRef

  73. 73

    Ira M. Bernstein, Amy Thibault, Joan A. Mongeon, Gary J. Badger. (2005) The Influence of Pregnancy on Arterial Compliance. Obstetrics & Gynecology 105:3, 621-625
    CrossRef

  74. 74

    Baha Sibai, Gus Dekker, Michael Kupferminc. (2005) Pre-eclampsia. The Lancet 365:9461, 785-799
    CrossRef

  75. 75

    Sven Cnattingius, Marie Reilly, Yudi Pawitan, Paul Lichtenstein. (2004) Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: A population-based Swedish cohort study. American Journal of Medical Genetics 130A:4, 365-371
    CrossRef

  76. 76

    Inanc Mendilcioglu, Bilal Trak, Mine Uner, Selda Umit, Mesut Kucukosmanoglu. (2004) Recurrent preeclampsia and perinatal outcome: a study of women with recurrent preeclampsia compared with women with preeclampsia who remained normotensive during their prior pregnancies. Acta Obstetricia et Gynecologica Scandinavica 83:11, 1044-1048
    CrossRef

  77. 77

    Shihfen Tu, Craig A. Mason. (2004) Organizing population data into complex family pedigrees: Application of a second-order data linkage to state birth defects registries. Birth Defects Research Part A: Clinical and Molecular Teratology 70:9, 603-608
    CrossRef

  78. 78

    Piet Hein Jongbloet. (2004) Offspring sex ratio at population level versus early and late onset preeclampsia. Early Human Development 79:2, 159-163
    CrossRef

  79. 79

    Lars J. Vatten, Rolv Skjaerven. (2004) Is pre-eclampsia more than one disease?. BJOG: An International Journal of Obstetrics and Gynaecology 111:4, 298-302
    CrossRef

  80. 80

    Emma Nilsson, Helena Salonen Ros, Sven Cnattingius, Paul Lichtenstein. (2004) The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. BJOG: An International Journal of Obstetrics and Gynaecology 111:3, 200-206
    CrossRef

  81. 81

    Lars J. Vatten, Rolv Skjærven. (2004) Offspring sex and pregnancy outcome by length of gestation. Early Human Development 76:1, 47-54
    CrossRef

  82. 82

    Dunja Tabs, Tihomir Vejnovic, Nebojsa Radunovic. (2004) Preeclampsia and eclampsia in parturients from the in vitro fertilization program. Medicinski pregled 57:1-2, 7-12
    CrossRef

  83. 83

    Tania Haddad. (2003) Update on Pre-eclampsia. International Anesthesiology Clinics 40:4, 115-135
    CrossRef

  84. 84

    Gus Dekker, Pierre-Yves Robillard. (2003) The birth interval hypothesis—does it really indicate the end of the primipaternity hypothesis. Journal of Reproductive Immunology 59:2, 245-251
    CrossRef

  85. 85

    William S Webster, Jane AD Freeman. (2003) Prescription drugs and pregnancy. Expert Opinion on Pharmacotherapy 4:6, 949-961
    CrossRef

  86. 86

    Keith R McCrae. (2003) Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management. Blood Reviews 17:1, 7-14
    CrossRef

  87. 87

    Susan Harlap, Ora Paltiel, Lisa Deutsch, Ariella Knaanie, Sausan Masalha, Efrat Tiram, Lee S. Caplan, Dolores Malaspina, Yechiel Friedlander. (2002) Paternal Age and Preeclampsia. Epidemiology 13:6, 660-667
    CrossRef

  88. 88

    Gabriella Pridjian, Jules B. Puschett. (2002) Preeclampsia. Part 1: Clinical and Pathophysiologic Considerations. Obstetrical & Gynecological Survey 57:9, 598-618
    CrossRef

  89. 89

    (2002) The Interval between Pregnancies and Preeclampsia. New England Journal of Medicine 346:23, 1831-1832
    Full Text

Letters